These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 33230612)
1. Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions. Shi X; He L; Zhang SM; Luo J Stem Cell Rev Rep; 2021 Jun; 17(3):862-877. PubMed ID: 33230612 [TBL] [Abstract][Full Text] [Related]
2. Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges. Ji J; Xu H; Li C; Luo J Tissue Eng Part B Rev; 2023 Aug; 29(4):441-455. PubMed ID: 36884294 [TBL] [Abstract][Full Text] [Related]
3. Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs. Luo J; Qin L; Zhao L; Gui L; Ellis MW; Huang Y; Kural MH; Clark JA; Ono S; Wang J; Yuan Y; Zhang SM; Cong X; Li G; Riaz M; Lopez C; Hotta A; Campbell S; Tellides G; Dardik A; Niklason LE; Qyang Y Cell Stem Cell; 2020 Feb; 26(2):251-261.e8. PubMed ID: 31956039 [TBL] [Abstract][Full Text] [Related]
4. Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts. Cong X; Zhang SM; Batty L; Luo J Stem Cells Dev; 2019 Dec; 28(24):1581-1594. PubMed ID: 31663439 [TBL] [Abstract][Full Text] [Related]
5. Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering. Luo J; Shi X; Lin Y; Yuan Y; Kural MH; Wang J; Ellis MW; Anderson CW; Zhang SM; Riaz M; Niklason LE; Qyang Y Acta Biomater; 2021 Jan; 119():184-196. PubMed ID: 33166710 [TBL] [Abstract][Full Text] [Related]
7. Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering. Luo J; Lin Y; Shi X; Li G; Kural MH; Anderson CW; Ellis MW; Riaz M; Tellides G; Niklason LE; Qyang Y Acta Biomater; 2021 Jan; 119():155-168. PubMed ID: 33130306 [TBL] [Abstract][Full Text] [Related]
8. Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells. Li ML; Luo J; Ellis MW; Riaz M; Ajaj Y; Qyang Y Methods Mol Biol; 2022; 2375():21-34. PubMed ID: 34591296 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Wang L; Hu J; Sorek CE; Chen EY; Ma PX; Yang B Expert Opin Biol Ther; 2016; 16(3):317-30. PubMed ID: 26560995 [TBL] [Abstract][Full Text] [Related]
11. Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts. Abutaleb NO; Truskey GA Cell Stem Cell; 2020 Feb; 26(2):136-137. PubMed ID: 32032523 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. Hibino N; Duncan DR; Nalbandian A; Yi T; Qyang Y; Shinoka T; Breuer CK J Thorac Cardiovasc Surg; 2012 Mar; 143(3):696-703. PubMed ID: 22244569 [TBL] [Abstract][Full Text] [Related]
13. Current Progress in Vascular Engineering and Its Clinical Applications. Jouda H; Larrea Murillo L; Wang T Cells; 2022 Jan; 11(3):. PubMed ID: 35159302 [TBL] [Abstract][Full Text] [Related]
14. Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans. Fang S; Ellman DG; Andersen DC Cells; 2021 Mar; 10(3):. PubMed ID: 33807009 [TBL] [Abstract][Full Text] [Related]
15. Keshavarzian M; Meyer CA; Hayenga HN Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930 [TBL] [Abstract][Full Text] [Related]
16. Tissue-engineered vascular grafts created from human induced pluripotent stem cells. Sundaram S; One J; Siewert J; Teodosescu S; Zhao L; Dimitrievska S; Qian H; Huang AH; Niklason L Stem Cells Transl Med; 2014 Dec; 3(12):1535-43. PubMed ID: 25378654 [TBL] [Abstract][Full Text] [Related]
17. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model. Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations. Krawiec JT; Weinbaum JS; Liao HT; Ramaswamy AK; Pezzone DJ; Josowitz AD; D'Amore A; Rubin JP; Wagner WR; Vorp DA Tissue Eng Part A; 2016 May; 22(9-10):765-75. PubMed ID: 27079751 [TBL] [Abstract][Full Text] [Related]
19. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells. Eoh JH; Shen N; Burke JA; Hinderer S; Xia Z; Schenke-Layland K; Gerecht S Acta Biomater; 2017 Apr; 52():49-59. PubMed ID: 28163239 [TBL] [Abstract][Full Text] [Related]
20. Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development. Radke D; Jia W; Sharma D; Fena K; Wang G; Goldman J; Zhao F Adv Healthc Mater; 2018 Aug; 7(15):e1701461. PubMed ID: 29732735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]